Mobia Medical, Inc. (NASDAQ:MOBI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $20.75.
MOBI has been the subject of several research analyst reports. Wall Street Zen upgraded Mobia Medical from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. The Goldman Sachs Group started coverage on Mobia Medical in a research report on Tuesday, June 2nd. They set a “buy” rating and a $31.00 target price for the company. Wolfe Research started coverage on shares of Mobia Medical in a report on Tuesday, June 2nd. They issued an “outperform” rating for the company. BTIG Research reissued a “buy” rating and issued a $19.00 target price on shares of Mobia Medical in a report on Wednesday. Finally, Weiss Ratings initiated coverage on shares of Mobia Medical in a research report on Wednesday. They issued a “sell (e-)” rating on the stock.
Check Out Our Latest Stock Report on Mobia Medical
Mobia Medical Stock Up 0.7%
Mobia Medical (NASDAQ:MOBI – Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million during the quarter. Mobia Medical’s revenue was up 102.4% on a year-over-year basis. On average, equities analysts expect that Mobia Medical will post -2.76 EPS for the current fiscal year.
Insider Activity at Mobia Medical
In other Mobia Medical news, CFO Nelson Bunker Curnes acquired 5,000 shares of the company’s stock in a transaction on Tuesday, June 9th. The stock was acquired at an average cost of $12.79 per share, with a total value of $63,950.00. Following the purchase, the chief financial officer directly owned 366,997 shares of the company’s stock, valued at approximately $4,693,891.63. This represents a 1.38% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.
About Mobia Medical
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.
Featured Stories
- Five stocks we like better than Mobia Medical
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Mobia Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mobia Medical and related companies with MarketBeat.com's FREE daily email newsletter.
